(ATHX:Consolidated Issue listed on NASDAQ Capital Market)
Richard Maziarz M.D.
Scientific & Clinical Advisor, Athersys, Inc.
|Age||Total Calculated Compensation||This person is connected to 23 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Richard Maziarz, M.D., serves as Scientific and Clinical Advisor of BTHC VI, Inc. Dr. Maziarz serves as Principal Investigator of Oregon Health Sciences University. Dr. Maziarz specializes in bone marrow transplantation and hematologic malignancies. His research interests cover function of the cellular immune system after bone marrow transplantation, molecular immunology and tumor immunology. Dr. Maziarz’s clinical interests include leukemia, lymphoma, graft vs. host ...
3201 Carnegie AvenuePhone: 216-431-9900
Cleveland, Ohio 44115
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Other Affiliations*There is no Company Affiliations data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Marc H. Hedrick M.D.||Chief Executive Officer, President, Director and Member of Executive Committee|
Cytori Therapeutics, Inc.
|Martin M. McGlynn||Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc|
|David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.||Chief Executive Officer and Director|
|Zami Aberman||Executive Chairman and Chief Executive Officer|
Pluristem Therapeutics, Inc.
|Mark R. Weinreb M.S.||Chairman, Chief Executive Officer and President|
BioRestorative Therapies, Inc.
|$675.0K||Compensation as of Fiscal Year 2014.|